Klonopin Withdrawal

Klonopin withdrawal can show up days after your last dose and linger, with rebound anxiety leading the way. Stopping abruptly can trigger seizures, but there's a safe way out: a supervised, gradual taper plus therapy.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Klonopin Withdrawal Is

You're not aloneDependence forms even when you take Klonopin exactly as prescribed. Needing help to stop isn’t a failure of willpower — it’s the expected biology of the drug.

If you take Klonopin and you’ve started cutting back, missed a dose, or you’re bracing to stop, what follows tells you what’s coming and how to get through it safely. Klonopin withdrawal is the cluster of physical and psychological symptoms that surface when a brain that has adapted to clonazepam suddenly has less of it to work with[1]. It is a recognized medical condition, not a sign of weakness, and it is the predictable flip side of how the drug works in the first place.

Here’s the part most people don’t know walking in. Because Klonopin is long-acting, its withdrawal doesn’t behave like the fast, sharp crash people picture from short-acting benzos. Symptoms can be delayed for two to three days after the last dose, and they can drag out longer[1]. That slower curve is uncomfortable in its own way, but it’s also part of why a planned, gradual taper off Klonopin can be smoother than coming off a faster drug.

The safe way off Klonopin is a supervised taper. Call 988 if you're in danger.
If you’re in danger right now or thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), any time.

What to do:

  • Get into a medically supervised taper. Lowering the dose in small, planned steps is the safe way to come off Klonopin, and a medical team carries the seizure risk so you don’t have to white-knuckle it alone — stopping abruptly is the part that’s dangerous. Find a Klonopin detox or taper →
  • If you’ve already stopped, don’t take a few quiet days as the all-clear. Klonopin’s long half-life can delay the danger window, so stay in touch with a clinician rather than going it solo.
  • If someone mixed Klonopin with opioids or alcohol and won’t wake up, call 911. Naloxone reverses opioids but not Klonopin — give it anyway if opioids may be involved, then call 911.

Find treatment today →

AddictionHelp.com Fast Facts
  • Klonopin withdrawal can be delayed. Because clonazepam is long-acting and clears the body slowly, symptoms may not start for two to three days after the last dose, later than with short-acting benzos[1].
  • The dangerous symptom is seizure. Stopping a benzodiazepine abruptly after regular use can trigger withdrawal seizures, and the risk runs highest after high doses and long-term use[2].
  • Rebound anxiety and insomnia are the hallmark. As the drug leaves, the very anxiety and sleeplessness it was treating can come roaring back, often more intense than before[3].
  • The way out is a supervised taper, and it works. A slow, planned dose reduction prevents the worst symptoms and brings most people off Klonopin safely — far gentler than the agony people picture when quitting alone[4].

Klonopin Withdrawal Symptoms

The symptoms fall into three buckets: physical, psychological, and rebound[1]. When clonazepam levels fall, the brain’s braking system — which had quieted down to balance the drug — is suddenly left underpowered, and the nervous system runs hot. Knowing which symptom is which takes a lot of the fear out of the first weeks.

Physical Symptoms of Klonopin Withdrawal

The body reacts first and most visibly. Benzodiazepine withdrawal produces a recognizable set of somatic and autonomic symptoms as the overexcited nervous system spills over[1].

Common physical symptoms include:

  • Tremors and muscle twitching — the kind of movement and tremor that the GABA system normally keeps in check[5]
  • Sweating, chills, and a racing or pounding heart
  • Headache and muscle aches or stiffness
  • Nausea, stomach upset, and loss of appetite
  • Dizziness and a sense of being unsteady on your feet
  • Heightened sensitivity to light, sound, and touch

These are uncomfortable but, on their own, not the dangerous part. A supervised taper is built specifically to keep them in the manageable range rather than letting them spike.

Psychological Symptoms of Klonopin Withdrawal

The mental and emotional side of Klonopin withdrawal is often the hardest to sit with, because it can feel like the original problem returning with interest. Stopping a benzodiazepine can bring a cluster of psychiatric symptoms alongside the physical ones[1].

People commonly describe:

  • Surging anxiety, agitation, and a sense of dread
  • Panic attacks, sometimes more intense than the ones Klonopin was prescribed to treat
  • Irritability and a short fuse
  • Trouble concentrating and a foggy, “not myself” feeling
  • Depressed mood and emotional rawness
  • Restlessness that makes it hard to settle

It helps to name what these are: not proof that you’ll never cope without the drug, but the visible sign of a nervous system that turned its own calming machinery down and now has to turn it back up. That process is the brain healing, not breaking.

Rebound Anxiety and Rebound Insomnia

What rebound meansRebound is the brief return of the symptoms a drug was holding down — here, anxiety and sleeplessness. It’s a passing overshoot as the brain re-balances, not the original problem coming back for good.

There’s a specific phenomenon worth separating out, because it catches people off guard. Rebound is the temporary return of the very symptoms the drug was treating — and with Klonopin, that means anxiety and sleep. Rebound insomnia and rebound anxiety are well-documented after benzodiazepine withdrawal, and they’re tied to how fast the drug leaves the body[3]. Benzodiazepines as a class are known to carry rebound insomnia, rebound anxiety, and an intense, sometimes prolonged withdrawal when use stops[6].

Here’s the crucial thing to understand. Rebound is usually temporary and self-limited. It tends to come on fast and then fade as the brain re-balances[1]. It is not the original anxiety disorder coming back permanently, and it is not a sign that you “need” the drug forever. A slow taper is designed precisely to soften this spike, and rebound symptoms are part of why a gradual reduction beats an abrupt stop[4].

Less Common but Serious Symptoms

Most people’s symptoms stay in the buckets above. But it’s worth knowing the rarer, more severe ends of the range, because they’re the reason medical supervision matters. Beyond seizures, abrupt withdrawal from a benzodiazepine or other sedative-hypnotic can, in uncommon cases, be complicated by hallucinations, delirium, or even catatonia[7]. Benzodiazepine withdrawal delirium specifically is recognized as a serious problem that needs prompt treatment[8].

The same severe end of the range — delirium, hallucinations, and seizures — is seen across other drugs that act on the GABA system, which underscores that this is about the biology of GABA withdrawal, not anything unusual about you[9]. These are not the typical experience, but they are exactly why doing it under medical eyes is not an overreaction.

Why Klonopin Withdrawal Happens at All

It helps to understand the engine under the symptoms, because once you see it, the whole experience stops feeling random. Withdrawal is the brain correcting an imbalance the drug created[1].

Your Brain Adapted Around the Drug

Klonopin amplifies GABA, the nervous system’s main “slow down” signal. Take it day after day and the brain compensates to keep its own balance — it quiets its calming machinery so the artificially boosted braking becomes the new normal. The trouble starts when the drug comes out. Suddenly the brain is left with too little of its own braking and an overexcited nervous system, and that overshoot is what you feel as withdrawal[1].

This is not a willpower problem and not a character flaw. It is the predictable biology of a brain that adapted to a drug that was always present, and it happens to people who took Klonopin exactly as prescribed[10].

Withdrawal Can Happen Even at a Prescribed Dose

A common and painful misconception is that only people who “abused” Klonopin go through withdrawal. Not so. Physical dependence forms from regular use, not from misuse, and stopping then brings symptoms regardless of how carefully you took the drug[11]. Many patients reach a point where they need to come off a benzodiazepine — because of side effects, lost effectiveness over time, or simply a wish to stop — and the withdrawal they face is the same biological event either way[12]. Knowing this matters, because shame keeps people from asking for help they have every right to.

Why Stopping Klonopin Suddenly Can Cause Seizures

This is the most important section on the page, so read it closely. The danger of Klonopin is not in stopping — it’s in stopping the wrong way. And the single thing that makes abrupt withdrawal dangerous is the risk of a seizure.

How the Seizure Risk Builds

Klonopin works by strengthening GABA, the brain’s main calming signal, which raises the threshold against seizures. Take it regularly and the brain adapts by turning its own braking down to compensate. Remove the drug all at once and there’s nothing holding the nervous system back — the brain is left in an overexcited, under-braked state, and that’s the setup for a seizure. Withdrawal seizures have been reported across short, medium, and long half-life benzodiazepines when they’re discontinued abruptly[2].

The mechanism is the mirror image of how benzodiazepines stop seizures in the first place: they’re the first-line, most effective drugs for preventing withdrawal seizures precisely because they restore that GABA braking[13]. Withdrawal seizures, in general, are acute symptomatic seizures driven by a sudden loss of that inhibitory tone in a brain that had grown to depend on it[14].

Who Is Most at Risk

The seizure risk isn’t equal for everyone. It climbs with dose and duration. Withdrawal seizures usually occur in people who have taken benzodiazepines for long periods and at high doses — but, importantly, they have also been reported after less than 15 days of use and at ordinary therapeutic doses[2]. In other words, a long, heavy history raises the odds, but no one should assume they’re immune because their dose was “normal.”

Almost all reported benzodiazepine withdrawal seizures are grand mal (generalized) seizures, and severity has ranged from a single episode to, in the worst untreated cases, coma and death[2]. That range is sobering, and it’s the whole reason a supervised taper matters.

The Long Half-Life Changes the Timing, Not the Rule

Here’s a wrinkle specific to Klonopin. Because clonazepam clears so slowly, the dangerous window can open later than people expect — the symptoms and the seizure risk can be delayed for days after the last dose rather than hitting within hours[1]. Some people read a few quiet days after stopping as proof they’re “fine,” let their guard down, and then get hit. The long half-life buys time and can make a taper smoother, but it does not cancel the rule. The safe way down is a supervised taper, because a benzodiazepine should not be stopped abruptly after regular use[2].

Klonopin Withdrawal Timeline

How long Klonopin withdrawal lasts, and when it starts, comes down to one fact above all: clonazepam is long-acting, so its timeline runs slower and later than a short-acting benzodiazepine’s. The speed at which a drug leaves the body sets the shape of its withdrawal[1]. With Klonopin, symptoms tend to come on gradually, peak over a week or two, and then ease, though for some people a tail of symptoms lingers longer.

Why Klonopin’s Onset Is Delayed

Half-life, in plain termsA drug’s half-life is how long it takes the body to clear half of it. A long half-life means the drug fades out slowly, which is why a long-acting benzodiazepine eases down gradually rather than dropping off a cliff.

With a short-acting benzo, levels drop fast and withdrawal can begin within hours. Klonopin is different. Because the drug clears so slowly, blood levels coast downward for days after the last dose, so withdrawal often doesn’t begin until two to three days out[1]. That delayed onset is the single most misunderstood feature of coming off Klonopin, and it’s why people who feel okay on day one shouldn’t assume they’re in the clear.

The General Phases, Start to Finish

The table below maps the rough arc most people follow. Treat it as a guide, not a guarantee — half-life varies widely from person to person, and dose and duration shift the timing[10].

Phase Rough timing What tends to happen
Onset Often 2 to 3 days after the last dose, later than short-acting benzos The long half-life finally clears enough that rebound anxiety, restlessness, and insomnia begin[1]
Peak Around the first 1 to 2 weeks Symptoms are most intense, and seizure risk is highest if the drug was stopped abruptly[2]
Easing Over the following several weeks Sleep and anxiety gradually steady as the brain re-balances its receptors[4]
Lingering Months, in some people Anxiety, insomnia, or sensory sensitivity that slowly fade — a protracted course recognized after stopping benzodiazepines[15]

A supervised taper smooths this whole curve, because the dose steps down gradually instead of dropping to zero.

When Symptoms Drag on into Protracted Withdrawal

A longer tail isn't permanentIf symptoms linger, it doesn’t mean you’re stuck on the drug or that something went wrong. It means the nervous system is still finishing its reset, and the symptoms recede as it does.

For a subset of people, withdrawal isn’t over in a few weeks. Some symptoms — usually anxiety, insomnia, and sensory sensitivity — can persist for months in a more drawn-out course. Persistent, protracted withdrawal syndromes are a recognized phenomenon after discontinuing psychotropic medications, benzodiazepines included[15]. Benzodiazepines specifically are noted for the potential of an intense and exceedingly prolonged withdrawal in some users[6].

This is real, and it can be discouraging — but it is not permanent damage, and it does not mean you have to stay on the drug. A slower taper and good clinical support are the tools that keep it manageable, and the symptoms recede as the nervous system finishes resetting.

Did you know?

The pace at which a drug leaves the body shapes its withdrawal. Decades of sleep-laboratory research found that rebound insomnia developed mainly after stopping benzodiazepines with a rapid or intermediate elimination rate — the faster-clearing drugs[3]. Klonopin sits on the slow-clearing end, which is part of why its withdrawal tends to arrive later and, with a proper taper, can be smoothed out rather than slammed on. The same long half-life that delays the onset is the feature a good taper puts to work for you.

How Klonopin Withdrawal Compares to Other Benzodiazepines

People often treat all benzos as interchangeable, but how fast each drug leaves the body changes the entire shape of its withdrawal[1]. Klonopin sits on the long-acting end, and that single fact explains most of how its withdrawal differs from a faster drug like Xanax.

Long-Acting Means Later, Slower, and Often Smoother to Taper

With a short-acting benzodiazepine, blood levels crash quickly, so withdrawal hits hard and early — and rebound insomnia in particular shows up mainly after stopping the faster-clearing benzos[3]. Klonopin’s slow clearance flips that script: onset is delayed, the curve is gentler, and the drug effectively eases itself down between dose reductions, which is part of why a long-acting agent is often used to anchor a smooth taper[16].

Feature Klonopin (clonazepam, long-acting) Short-acting benzo (e.g., Xanax)
Onset of withdrawal Delayed, often 2 to 3 days after the last dose Fast, sometimes within hours
Symptom curve Slower to peak, more drawn out Sharper, earlier peak
Rebound insomnia/anxiety Present but often less abrupt More pronounced with rapid clearance[3]
Suitability for a smooth taper Long half-life helps steady the drop Often switched to a longer-acting drug to taper

The Seizure Rule Applies to Every Benzo

One thing does not change with half-life: the seizure danger of abrupt cessation applies across the board. Withdrawal seizures have been reported with short, medium, and long half-life benzodiazepines alike when they’re stopped suddenly[2]. Klonopin’s slow clearance may delay the danger, but it does not remove it — which is why the rule is the same for every drug in this family: taper, don’t quit cold. To see how the recognition signs and the path off differ for the faster drugs, compare with Xanax and how to come off it, and the wider benzodiazepine family.

The Way Out Is a Supervised Klonopin Taper

Now the part that should take the fear down several notches. The solution to a dangerous withdrawal isn’t to keep using — it’s to come off slowly and on purpose, with a medical team. A gradual, structured dose reduction is the recognized standard for stopping a benzodiazepine, and it is the opposite of the cold-turkey scenario people dread.

A Gradual Taper Is the Standard of Care

Worth asking“Can we map out a slow, scheduled taper instead of stopping at once — and what symptoms mean we should slow it down?”

The evidence here is consistent and clear. A gradual taper is preferred over abrupt cessation, specifically to avoid rebound insomnia and withdrawal symptoms[4]. Discontinuing a benzodiazepine is genuinely challenging because of the withdrawal symptoms and the return of the original complaints — which is exactly why it should be planned and supervised rather than improvised[12].

The goal of a taper is simple. You lower the dose in small, scheduled steps so the brain has time to re-grow its braking at each stage, instead of being thrown into freefall.

What a supervised taper changes:

  • It heads off the seizures and severe symptoms that come from stopping suddenly, because the dose comes down in small, planned steps[2]. And if a seizure risk does emerge, a medical team can act on it, because benzodiazepines themselves are the evidence-based tool for preventing withdrawal-seizure recurrence[17].
  • Klonopin’s long half-life works in your favor, smoothing the drop between dose reductions in a way short-acting benzodiazepines can’t[1].
  • It can be paired with support and, where appropriate, adjunct medication. Some anti-seizure medications are used alongside a taper to mitigate withdrawal symptoms during benzodiazepine discontinuation[18].

Therapy and Support Make the Taper Hold

A taper is the spine, but it’s not the whole treatment. Pairing the dose reduction with structured psychological support gives the best odds of getting off Klonopin and staying off. Cognitive behavioral therapy improves the odds of successfully discontinuing these drugs — and behavioral therapy on its own does too, with clear written information about the plan helping as well[4]. For people stopping benzodiazepines used for sleep, decision aids and tapering paired with CBT for insomnia are part of the modern toolkit[19]. The counseling is what carries you through the rough days and helps the change last.

Even High-Dose, Long-Term Use Comes off Safely

If you’re on a high dose, or you’ve been taking Klonopin for years, it’s easy to assume you’re too far gone to stop. You aren’t. Even high-dose benzodiazepine dependence can be brought off successfully with the right structure: in one documented case, a patient on a high daily dose was tapered safely over roughly 28 weeks using long-acting clonazepam and close monitoring[16].

The lesson isn’t the exact schedule — it’s that a slow, supervised, well-monitored taper works even at the hard end of the spectrum. Rational, planned discontinuation strategies exist for benzodiazepines, and they’re the path clinicians follow[20]. Evidence-based guidance on how to come off these medications properly is exactly what makes a safe, personalized stop possible[21].

Why Mixing Klonopin Is the Real Overdose Danger

Withdrawal isn’t the only risk worth naming with Klonopin. Taken alone, benzodiazepines are relatively forgiving compared with opioids. The deadly danger shows up in combination — and that matters most for anyone tempted to keep using to dodge withdrawal.

Klonopin with Opioids or Alcohol Can Stop Your Breathing

Klonopin slows the nervous system. So do opioids. So does alcohol. Stack any of them together and the drive to breathe can shut down. This isn’t a rare edge case: benzodiazepines have been implicated in roughly 30% of opioid overdose deaths, because each drug amplifies the other’s effect on breathing[6].

If you take Klonopin, the single most dangerous thing you can do is combine it with another sedating substance — and every doctor and pharmacist you see should know you’re on it.

Naloxone Reverses Opioids, Not Klonopin

Carry one life-or-death distinction with you. Naloxone (Narcan) reverses an opioid overdose, but it does not reverse Klonopin or any other benzodiazepine. In a mixed overdose, naloxone can still be life-saving by reversing the opioid part, so give it if opioids may be involved — and call 911 regardless, because the Klonopin effect and the breathing risk can continue after the opioid is reversed.

The takeaway is the same one the whole subject keeps pointing to. The safest way to leave Klonopin behind is a supervised taper, never a risky workaround.

Getting Help with Klonopin Withdrawal

If Klonopin has taken more of your life than you meant to give it, here’s what to hold onto. This is a treatable condition, stopping safely is entirely possible, and a medically supervised taper makes the process far gentler than quitting alone — which is the one thing you should not do.

Whether you’ve followed every instruction your doctor gave or things slipped out of your hands, the path is the same. Don’t stop on your own, get into a supervised detox or taper, and lean on the counseling that makes it stick. The agony people picture is the picture of someone quitting all at once and by themselves. A medically guided taper is a different experience, and it’s the one that actually works[4]. Start a supervised taper today and the seizure danger of cold-turkey quitting largely disappears, while the life on the other side is steadier than the one you’re white-knuckling now.

To understand the drug itself and how dependence builds, start with clonazepam and how it takes hold. To see the supervised setting that carries the seizure risk for you, learn how a medical Klonopin detox works, and for the day-to-day of getting well, read what Klonopin rehab looks like. For the wider family of drugs Klonopin belongs to, see the benzodiazepines and how to come off them.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

What are the symptoms of Klonopin withdrawal?

Klonopin (clonazepam) withdrawal symptoms fall into three groups. Physical: tremors, sweating, a racing heart, headache, muscle aches, nausea, dizziness, and heightened sensitivity to light, sound, and touch. Psychological: surging anxiety, panic attacks, irritability, trouble concentrating, depressed mood, and restlessness[1]. And rebound, the temporary return of the anxiety and insomnia the drug was treating, often more intense than before[3]. In rare, usually abrupt-stop cases, withdrawal can be more severe, including seizures, and uncommonly delirium or hallucinations[7]. A supervised taper is designed to keep symptoms in the manageable range.

How long does Klonopin withdrawal last?

Longer than withdrawal from a short-acting benzodiazepine, because clonazepam is long-acting and clears the body slowly. Symptoms often do not begin until two to three days after the last dose, later than people expect[1]. For most people the sharpest symptoms cluster in the first one to two weeks and then ease over the following weeks as the brain re-balances[4]. For some, a tail of anxiety, insomnia, or sensory sensitivity can linger for months, a recognized protracted course after stopping benzodiazepines[15]. A slow, supervised taper keeps symptoms manageable the whole way through.

Why is Klonopin withdrawal delayed compared to other benzos?

Because clonazepam is long-acting. The speed at which a drug leaves the body sets the shape of its withdrawal, and Klonopin leaves slowly[1]. With a short-acting benzo, blood levels drop fast and withdrawal can begin within hours. With Klonopin, levels coast downward for days after the last dose, so symptoms often do not start until day two or three. The downside is a later, longer course. The upside is that the same long half-life can make a gradual taper smoother, because the drug eases itself down between dose reductions.

Can you have a seizure from stopping Klonopin?

Yes, if you stop abruptly after regular use. Klonopin raises the seizure threshold by boosting GABA, the brain’s calming signal, and the brain adapts by turning its own braking down. Remove the drug all at once and the nervous system is left overexcited, which can trigger a seizure. Withdrawal seizures occur across short, medium, and long half-life benzodiazepines when discontinued abruptly[2]. The risk is highest after high doses and long-term use, but seizures have also been reported after less than 15 days of use and at ordinary doses, and almost all are grand mal seizures[2]. This is exactly why you should not quit cold turkey. A medically supervised taper prevents it.

What is the safest way to stop taking Klonopin?

A medically supervised, gradual taper. A gradual taper is preferred over abrupt cessation specifically to avoid rebound symptoms and withdrawal, including the seizure risk[4]. The dose comes down in small, scheduled steps so the brain can re-grow its braking at each stage instead of being thrown into freefall. Klonopin’s long half-life actually helps here, smoothing the drop between reductions[1]. Pairing the taper with therapy improves the odds of stopping for good[4], and even high-dose, long-term use can be brought off safely with the right structure[16]. You can find a supervised taper or detox at /benzodiazepines/klonopin/detox/.

Does naloxone (Narcan) reverse a Klonopin overdose?

No. Naloxone reverses opioid overdoses but does not reverse Klonopin or other benzodiazepines. The most dangerous overdoses involve mixing, because Klonopin, opioids, and alcohol each slow breathing and combining them can stop it. Benzodiazepines are implicated in roughly 30% of opioid overdose deaths[6]. If someone is unresponsive or breathing slowly, call 911. Still give naloxone if opioids may be involved, because it can reverse the opioid part, but call 911 regardless since the Klonopin effect continues. If you are trying to stop Klonopin, the safe way out is a supervised taper, and you can find help at /find-treatment-help/.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

21 Sources
  1. Wisłowska-Stanek A, Jarkiewicz M, Mirowska-Guzel D (2025). Rebound effect, discontinuation, and withdrawal syndromes associated with drugs used in psychiatric and neurological disorders. Pharmacological reports : PR. https://doi.org/10.1007/s43440-024-00689-z
  2. Hu X (2011). Benzodiazepine withdrawal seizures and management. The Journal of the Oklahoma State Medical Association.
  3. Kales A, Soldatos CR, Bixler EO, Kales JD (1983). Rebound insomnia and rebound anxiety: a review. Pharmacology. https://doi.org/10.1159/000137794
  4. Hintze JP, Edinger JD (2020). Hypnotic Discontinuation in Chronic Insomnia. Sleep medicine clinics. https://doi.org/10.1016/j.jsmc.2020.02.003
  5. Sáenz-Farret M, Tijssen MAJ, Eliashiv D, Fisher RS, Sethi K, Fasano A (2022). Antiseizure Drugs and Movement Disorders. CNS drugs. https://doi.org/10.1007/s40263-022-00937-x
  6. Cardona-Acosta AM, Meisser N, Vardeleon NI, Steiner H, Bolaños-Guzmán CA (2025). Mother's little helper turned a foe: Alprazolam use, misuse, and abuse. Progress in neuro-psychopharmacology & biological psychiatry. https://doi.org/10.1016/j.pnpbp.2024.111137
  7. Oldham MA, Desan PH (2016). Alcohol and Sedative-Hypnotic Withdrawal Catatonia: Two Case Reports, Systematic Literature Review, and Suggestion of a Potential Relationship With Alcohol Withdrawal Delirium. Psychosomatics. https://doi.org/10.1016/j.psym.2015.12.007
  8. Yamaguchi J, Sadahiro R, Wada S, Nishikawa E, Terada T, Nakahara R, et al. (2025). Potential Effectiveness of Yokukansan and Lemborexant as Alternative Candidates to Benzodiazepines to Prevent Benzodiazepine Withdrawal Delirium in the Cancer Perioperative Period: A Case Report and Literature Review. Neuropsychopharmacology reports. https://doi.org/10.1002/npr2.70062
  9. Feldman R, Autry B, Dukes J, Lofy T, Marchetti G, Patt A, et al. (2023). A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal. Clinical toxicology (Philadelphia, Pa.). https://doi.org/10.1080/15563650.2023.2285702
  10. Dokkedal-Silva V, Berro LF, Galduróz JCF, Tufik S, Andersen ML (2019). Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use. Harvard review of psychiatry. https://doi.org/10.1097/hrp.0000000000000227
  11. Cohen D, Recalt A (2019). Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review. Psychotherapy and psychosomatics. https://doi.org/10.1159/000496733
  12. Welsh JW, Tretyak V, McHugh RK, Weiss RD, Bogunovic O (2018). Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2018.04.028
  13. Caspar R, Fortenberry K, Leiser J, Ose D, Nashelsky J (2021). Which detoxification regimens are effective for alcohol withdrawal syndrome?. The Journal of family practice. https://doi.org/10.12788/jfp.0157
  14. Skryabin V, Malygina A, Sokolova S (2026). Alcohol Withdrawal Seizures: Neurobiological Mechanisms, Clinical Predictors, and Evidence- Based Management. Journal of psychiatric practice. https://doi.org/10.1097/pra.0000000000000927
  15. Cosci F, Chouinard G (2020). Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and psychosomatics. https://doi.org/10.1159/000506868
  16. Loscertales HR, Wentzky V, Dürsteler K, Strasser J, Hersberger KE, Arnet I (2017). Successful withdrawal from high-dose benzodiazepine in a young patient through electronic monitoring of polypharmacy: a case report in an ambulatory setting. Therapeutic advances in psychopharmacology. https://doi.org/10.1177/2045125317690502
  17. Koh JJ, Malczewska M, Doyle-Waters MM, Moe J (2021). Prevention of alcohol withdrawal seizure recurrence and treatment of other alcohol withdrawal symptoms in the emergency department: a rapid review. BMC emergency medicine. https://doi.org/10.1186/s12873-021-00524-1
  18. Dueno MR, Howington GT, Ryan M (2026). Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation. The mental health clinician. https://doi.org/10.9740/mhc.2026.06.141
  19. Aoki Y, Takaesu Y, Suzuki M, Okajima I, Takeshima M, Shimura A, et al. (2022). Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics. Neuropsychopharmacology reports. https://doi.org/10.1002/npr2.12219
  20. Vinkers CH, Kupka RW, Penninx BW, Ruhé HG, van Gaalen JM, van Haaren PCF, et al. (2024). Discontinuation of psychotropic medication: a synthesis of evidence across medication classes. Molecular psychiatry. https://doi.org/10.1038/s41380-024-02445-4
  21. van Haaren PCF, van Gaalen JM, Kupka RW, Penninx BWJ, Ruhé HG, Schellekens AFA, et al. (2024). [Discontinuation of psychotropic medication: a critical review of the evidence]. Tijdschrift voor psychiatrie.
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.